News Release

Twin study lends new insights into link between back pain and depression

Association may be explained by shared genetic and environmental factors, suggests study in PAIN

Peer-Reviewed Publication

Wolters Kluwer Health

February 26, 2015 - Genetic factors help to explain the commonly found association between low back pain and depression, suggests a large study of twins in the March issue of PAIN®, the official publication of the International Association for the Study of Pain. The journal is published by Wolters Kluwer.

Genetic factors affecting both conditions may be involved in the association between back pain and depression, according to the report by Marina B. Pinheiro, MSc, and colleagues of The University of Sydney, Australia, and Murcia Twin Registry, Spain.

Twin Data Used to Explore Link between Back Pain and Depression

The researchers analyzed data from an established database (Murcia Twin Registry) of nearly 2,150 Spanish twins. Twin studies provide a unique opportunity to elucidate the association between health conditions, by eliminating the genetic and environmental factors contributing to them.

Questionnaire responses were analyzed to determine whether participants with symptoms of depression had higher prevalence of back pain. A series of statistical analyses were then performed to clarify the contributions of genetic factors and early shared environment to the depression-back pain link.

The results showed a significant association between symptoms of depression and low back pain. On initial analysis considering the participants as individuals, rather than twins--and therefore not accounting for genetic and familial factors--the odds of having back pain were about 1.6 higher for those with symptoms of depression and anxiety.

On analysis of twin pairs--which controls for genetic and familial factors that could influence the relationship between depression and back pain--the relationship remained significant, with a 1.7 increase in odds. The association was even stronger--more than a 2.3 increase in odds of low back pain associated with depression and anxiety--on analysis of dizygotic (non-identical) twins, who share half their genes.

Genetic Factors Are 'Main Confounder' of Depression/Back Pain Link

On further analysis of monozygotic twins--who are genetically identical--the association between symptoms of depression and low back pain disappeared. This suggested that the strong association found in non-identical twins resulted from the "confounding" effects of common genetic factors influencing both conditions. For example, genes affecting levels of neurotransmitters such as serotonin and norepinephrine might affect the risk of both conditions.

Previous studies have shown a "consistent relationship" between back pain and depression--a combination that may complicate diagnosis and treatment. However, the nature of the association remains unclear. The new study is the first to examine the relationship between depression and low back pain using twin data to control for genetic and familial factors.

The finding that the association disappears after fully adjusting for genetics and familial confounders in identical twins suggests that "genetics is the main confounder" of the relationship between depression and back pain. Thus the commonly found association between these health conditions is probably not a true relationship, as there are other factors influencing it.

However, "It still remains unclear whether common genetic factors predispose people to develop both low back pain and depression," Pinheiro and coauthors write. Further studies in which participants are followed up over time--preferably twins--are needed to confirm the findings. The authors also suggest that the link between anxiety and back pain warrants further study.


Click here to read "Genetics and the environment affect the relationship between depression and low back pain: a co-twin control study of Spanish twins."

Article: "Genetics and the environment affect the relationship between depression and low back pain: a co-twin control study of Spanish twins" (doi:10.1097/01.j.pain.0000460330.56256.25)

About PAIN

PAIN is IASP's official journal. Published monthly, PAIN presents original research on the nature, mechanisms, and treatment of pain. Available to IASP members as a membership benefit, this peer-reviewed journal provides a forum for the dissemination of multidisciplinary research in the basic and clinical sciences. It is cited in Current Contents and Index Medicus.

About the International Association for the Study of Pain

IASP is the leading professional forum for science, practice, and education in the field of pain. Membership is open to all professionals involved in research, diagnosis, or treatment of pain. IASP has more than 7,000 members in 133 countries, 90 national chapters, and 20 special interest groups (SIGs). IASP brings together scientists, clinicians, healthcare providers, and policymakers to stimulate and support the study of pain and to translate that knowledge into improved pain relief worldwide.

About Wolters Kluwer Health

Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health's market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Follow our official Twitter handle: @WKHealth

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.